Three-Times-Weekly Administration of Teriparatide Improves Vertebral and Peripheral Bone Density, Microarchitecture, and Mechanical Properties Without Accelerating Bone Resorption in Ovariectomized Rats

Daily and weekly administration of teriparatide (PTH(1–34)) reduces the risk of osteoporotic bone fractures. However, their effects on markers of bone formation and bone resorption differ. These results indicate that the dosing frequency of teriparatide may affect bone metabolism and bone structure,...

Descripción completa

Detalles Bibliográficos
Autores principales: Takao-Kawabata, Ryoko, Isogai, Yukihiro, Takakura, Aya, Shimazu, Yukari, Sugimoto, Emika, Nakazono, Osamu, Ikegaki, Ichiro, Kuriyama, Hiroshi, Tanaka, Shinya, Oda, Hiromi, Ishizuya, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491365/
https://www.ncbi.nlm.nih.gov/pubmed/25911187
http://dx.doi.org/10.1007/s00223-015-9998-0

Ejemplares similares

Ejemplares similares